English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/41895
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by β-lactam-susceptible and highly resistant pneumococci.

AuthorsRodríguez-Cerrato, Violeta; Prado, Gema del; Huelves, Lorena; Naves, Plínio; Ruiz, Vicente; García, Ernesto ; Ponte, Carmen; Soriano, Francisco
KeywordsStreptococcus pneumoniae
Antibiotic resistance
Sepsis
Novobiocin
Pneumococcal infections
Anti-bacterial agents
Microbial sensitivity tests
Bacterial drug resistance
Issue DateJun-2010
PublisherElsevier
International Society of Chemotherapy
CitationInternational Journal of Antimicrobial Agents, 35(6): 544-549 (2010)
AbstractTherapeutic alternatives are needed against infections caused by highly multidrug-resistant Streptococcus pneumoniae. Novobiocin, an old antibiotic, was tested in vitro and in a murine sepsis model against one amoxicillin-susceptible and three amoxicillin-resistant strains [minimum inhibitory concentrations (MICs) 8–64mg/L]. Novobiocin MICs for all strains were 0.25–0.5mg/L. In sepsis, novobiocin and amoxicillin were evaluated at 25, 50, 100 and 200mg/kg given at 1, 5, 24 and 48h post bacterial challenge. The most effective regimens in animals infected with the amoxicillin-susceptible strain were 200mg/kg novobiocin and 25mg/kg amoxicillin, achieving 100% survival and undetectable organisms in the peritoneum. Among mice infected with amoxicillin-resistant S. pneumoniae, 200mg/kg novobiocin gave the highest protection (90–100% survivors), followed by 200mg/kg amoxicillin (60–100%), 100mg/kg novobiocin (50–87.5%) and 50mg/kg amoxicillin (14.3–25%). The killing effect of antibiotics in the peritoneum (mean Δlog10 colony-forming units/mL between treated and control mice) was as follows: 200mg/kg novobiocin (−6.6)>200mg/kg amoxicillin (−5.6)>100mg/kg novobiocin (−3.7)>50mg/kg amoxicillin (−0.7). Total plasma and ultrafiltrate pharmacokinetics of novobiocin (200mg/kg, single dose) in non-infected mice showed, respectively, half-lives of 151min and 215min, area under the concentration–time curves (AUCs) of 945.0mg h/L and 136.6mg h/L and maximal concentrations of 147mg/L and 18mg/L. Novobiocin may be a promising agent for therapy of highly β-lactam-resistant pneumococcal infections.
Description[EN]Manuscript accepted version for publication. [ES]Versión aceptada del manuscrito para su publicación.
Publisher version (URL)http://dx.doi.org/10.1016/j.ijantimicag.2010.02.007
URIhttp://hdl.handle.net/10261/41895
DOI10.1016/j.ijantimicag.2010.02.007
E-ISSN0924-8579
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
Rodriguez-Cerrato_2010_2ndRev_ijantimicag.pdf257,53 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.